Florence Coussy
Inserm(FR)Université Paris Cité(FR)Immunité et Cancer(FR)Institut Curie(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Risks and Factors, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics
Most-Cited Works
- → A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)(2016)278 cited
- → Circulating tumor cells: clinical validity and utility(2017)216 cited
- → Genomics to select treatment for patients with metastatic breast cancer(2022)160 cited
- → Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial(2021)154 cited
- → BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers(2020)137 cited
- → PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance(2020)123 cited